Sunday, September 8, 2013 {#s1}
=========================

Conference-Hall Sector B+C

**9:00--10:00 Registration**

**10:00--13:00 Advances in Vaccine Research (I)**

Chairs: R.M. Khaitov, member of the Russian Academy of Sciences and Russian Academy of Medical Sciences, M.D., Professor, Director of the National Research Centre Institute of Immunology, Federal Medical and Biological Agency of Russia,

N.A. Malyshev, M.D., Professor, Chief Physician of Clinical Hospital for Infectious Diseases No.1 of the Moscow Health Department, Russia

**KEYNOTE PRESENTATION:**

**E.V. Karamov, R.M. Khaitov**

National Research Centre Institute of Immunology, FMBA of Russia

101 - Biomedical Prevention of HIV/AIDS in Russia (30 min.)

G.O. Gudima

National Research Centre Institute of Immunology, FMBA of Russia

102 - HIV/AIDS Vaccines in Russia: Clinical Trials and Estimation of Acceptance in Population (20 min.)

I.A. Kofiadi

National Research Centre Institute of Immunology, FMBA of Russia

103 - Genetic Factors Defining Resistance and Susceptibility to HIV/AIDS (20 min.)

**A.V. Filatov, D.V. Mazurov**

National Research Centre Institute of Immunology, FMBA of Russia

104 - Cell-to-cell Transmission of HIV-1: Role of Virological Synapse (15 min.)

**11:25--11:40 Break**

**I.A.Nikolaeva**

National Research Centre Institute of Immunology, FMBA of Russia

105 - Rationale for HIV/AIDS Vaccines Design (20 min.)

**R.I.Ataullakhanov**

National Research Centre Institute of Immunology, FMBA of Russia

106 - Enhance Expression of Transgene in Adenovirus (15 min.)

**S.V.Korobova**

National Research Centre Institute of Immunology, FMBA of Russia

107 - The Modern Methods of HIV/AIDS Vaccine Evaluation (15 min.)

**M.M.Shmarov**

Gamaleya Scientific Research Institute of Epidemiology and Microbiology of the Health Ministry of the Russian Federation

108 - Development of Universal Vaccines against Flu (15 min.)

**A.V.Tkachuk**

Gamaleya Scientific Research Institute of Epidemiology and Microbiology of the Health Ministry of the Russian Federation

109 - Genetically Engineered Tuberculosis Subunit Vaccine (15 min.)

**13:00--14:00 Lunch**

14:00--17:30 Advances in Vaccine Research (II)

Chairs: A.L.Ginzburg, Vice President of the Russian Academy of Medical Sciences, M.D., Professor, Director of Gamaleya Scientific Research Institute of Epidemiology and Microbiology of the Health Ministry of the Russian Federation,

A.P.Kozlov, Doctor of Biological Sciences, Professor, Director of the Biomedical Centre (St.Petersburg, Russia)

**Antonio Lanzavecchia, MD**

Director of the Institute for Research in Biomedicine (Switzerland)

110 - Keynote presentation: Broadly Neutralizing Antibodies for Serotherapy and Vaccine Design (30 min.)

**Alexander Schmidt, MD**

Director, Clinical Research and Translational Science, GlaxoSmithKline Biologicals (US)

111 - Update on Dengue Vaccines (20 min.)

**Li Xiuling[\*](#fn1){ref-type="fn"}**

National Vaccine and Serum Institute (China)

112 - Development of Enterovirus 71 Vaccine (20 min.)

**Shen Shuo, PhD[\*](#fn1){ref-type="fn"}**

Wuhan Institute of Biological Product (China)

113 - Epidemics of Acute Gastroenteritis Caused by Viruses and Vaccine Development in China (20 min.)

**Luigi Buonaguro, MD[\*](#fn1){ref-type="fn"}**

Ist. Naz.Tumori "Fond. G. Pascale" (Italy)

114 - Virus-Like Particles and Particle Vaccines (20 min.)

**15:50--16:10 Break**

**Dan Barouch, MD, PhD**

Director of the Centre for Virology and Vaccine Research in the Department of Medicine at Beth Israel Deaconess Medical Center (US)

115 - Novel HIV Vaccine Strategies (20 min.)

**Jay A. Berzofsky, MD, PhD**

Chief, Vaccine Branch, Center for Cancer Research, National Cancer Institute (US)

116 - Strategies and Mechanisms for Induction of Mucosal T Cell Immunity (20 min.)

**HONORARY LECTURE:**

**José Esparza, MD, PhD**

Senior Advisor on HIV Vaccines of the Bill and Melinda Gates Foundation (US)

117 - 30 Years of HIV Vaccine Research (40 min.)

Monday, September 9, 2013 {#s2}
=========================

Grand Conference-Hall

**9:30--12:00 Advances in Antiviral Drug Discovery (I)**

Chairs: A.I. Mazus, M.D., Professor, Head of the Moscow City Centre for AIDS Prevention and Treatment (Russia)[\*](#fn1){ref-type="fn"},

Robert R. Redfield, M.D., Associate Director of the Institute of Human Virology, University of Maryland School of Medicine (US)[\*](#fn1){ref-type="fn"}

**PLENARY LECTURE:**

**Jan Balzarini, MD, PhD**

Laboratory of Virology and Chemotherapy, Rega Institute (Belgium)

118 - The Dense Glycan Shield on the HIV Envelope: the Achilles Heel of the Virus? (30 min.)

**John G. Bartlett, MD**

Director, HIV Care Program, The Johns Hopkins Hospital (US)

119 - The Anti-HIV Drug Pipeline (20 min.)

**S.N.Kochetkov**

Laboratory of Enzymology of Transcription, Engelhardt Institute of Molecular Biology, Russian Academy of Sciences

120 - Development of New HIV Inhibitors (20 min.)

**Fujie Zhang, MD[\*](#fn1){ref-type="fn"}**

National Centre for AIDS/STD Control and Prevention (China)

121 - Progress, Achievements and Challenges: a Review of China's Free Antiretroviral Therapy Program (20 min.)

**Anders Vahlne, MD[\*](#fn1){ref-type="fn"}**

Karolinska Institute (Sweden)

122 - Peptide Inhibitors of HIV (20 min.)

**James Rooney, MD**

Vice President of Medical Affairs, Gilead Sciences, Inc. (US)

123 - New Antiretroviral Therapies (20 min.)

**Leonid Margolis, PhD**[\*](#fn1){ref-type="fn"}

Head, Section of Intercellular Interactions, Eunice Kennedy Shriver National Institute of Child Health and Human Development (US)

124 - HIV Transmission and Pathogenesis in ex vivo Tissues (20 min.)

**12:00--13:00 Lunch**

**13:00--14:00 Official Opening Ceremony of the Conference**

**Welcoming Remarks**

**14:00--14:45 Special Opening Lecture**

**A.I. Mazus, M.D., PhD, Head, Moscow Center for HIV/AIDS Treatment and Prevention, welcoming Ram Petrov, MD, PhD, Head, Immunology Section, Institute of Bioorganic Chemistry, Russian Academy of Sciences who will introduce Robert C. Gallo, M.D., Director and Professor Institute of Human Virology, University of Maryland School of Medicine, Member, United States National Academy of Sciences and Co-Founder of the Global Virus Network**

**Robert C. Gallo, MD[\*](#fn1){ref-type="fn"}**

Institute of Human Virology, University of Maryland School of Medicine (US)

A personal journey with human retroviruses

**14:45--15:00 Break**

**15:00--17:00 Advances in Antiviral Drug Discovery (II)**

Chairs: C. David Pauza, Ph.D., Associate Director of the Institute of Human Virology, University of Maryland School of Medicine (US)[\*](#fn1){ref-type="fn"},

Leonid Margolis, Doctor of Biological Sciences, Professor, Chief of the Section of Intercellular Interactions (National Institutes of Health)(US)[\*](#fn1){ref-type="fn"}

**Alain Lafeuillade, MD[\*](#fn1){ref-type="fn"}**

Progress toward a HIV cure

125 - Department of Infectious Diseases, Toulon General Hospital (France) (20 min.)

**Luis Menéndez-Arias, PhD[\*](#fn1){ref-type="fn"}**

Centro de Biología Molecular "Severo Ochoa" (CSIC-UAM) (Spain)

126 - Questions and challenges in HIV drug resistance: A molecular perspective (20 min.)

**Vadim Bichko, MD**

Viriom Ltd. (Russia)

127 - Safety, pharmokinetics and efficacy of VM-1500, a novel reverse transcriptase inhibitor, In healthy volunteers and HIV-infected patients (20 min.)

**Ulrike Protzer, MD[\*](#fn1){ref-type="fn"}**

Institute of Virology TU Munich (Germany)

128 - Cure of HBV infection: can APOBEC3 deaminases mediate it? (20 min.)

**A.I. Mazus, MD[\*](#fn1){ref-type="fn"}**

Director, Moscow Center for HIV/AIDS Treatment and Prevention (Russia)

Summary remarks (10 min.)

**16:30--16:45 IHV Lifetime Achievement Award for Scientific Research to Vadim Agol, MD, PhD., DSc**

Introduction by Leonid Margolis, PhD.

**16:45--17:00 IHV Lifetime Achievement Award for Public Health to Jose Esparza, MD, PhD**

Introduction by Robert C. Gallo, MD

**17:00--17:45 Special Lecture Honoring the IHV Lifetime Achievement Award Winners**

**Konstantin Chumakov, PhD[\*](#fn1){ref-type="fn"}**

Chief of the Laboratory of Method Development, Division of Viral Products in the Food and Drug Administration (US)

129 - Polio Vaccines: The Past, Present and the Future

**17:45 Adjourn**

**19:30 IHV Gala Awards Banquet**

**Yar Restaurant**

Tuesday, September 10, 2013 {#s3}
===========================

Conference-Hall Sector B+C

**9:00--12:15 Mechanisms of Viral Pathogenesis**

Chairs: Peter Horal, Ph.D., University of Gothenburg (Sweden)[\*](#fn1){ref-type="fn"}

B.S. Naroditsky, Ph.D., Prof, Assistant Director, Gamaleya Scientific Research Institute of Epidemiology and Microbiology of the Health Ministry of the Russian Federation

**REINHARD KURTH HONORARY LECTURE---Introduction by Robert C. Gallo, MD[\*](#fn1){ref-type="fn"}: William Hall, MD[\*](#fn1){ref-type="fn"}**

University College, Dublin (Ireland)

130 - HTLV-I and Adult T Cell Leukemia/Lymphoma (ATLL): Cellular and Molecular Basis of Transformation (30 min.)

**Stephan Becker, PhD[\*](#fn1){ref-type="fn"}**

Institute of Virology at the University of Marburg (Germany)

131 - Replication and Assembly of Filoviruses (20 min.)

**Guido Poli, MD[\*](#fn1){ref-type="fn"}**

Head, AIDS Immunopathogenesis Unit, San Raffaele Scientific Institute (Italy)

132 - A Novel Pathway of Proviral HIV-1 Latency Regulated by Aminoacid Starvation and HDAC-4 (20 min.)

**Erica Ollmann Saphire, PhD[\*](#fn1){ref-type="fn"}**

Department of Immunology and Microbial Science of the Scripps Research Institute (US)

133 - Ebola virus matrix: structural transformation begets multiple structures in the virus life cycle (20 min.)

**Massimo Palmarini, DVM, PhD, FRSE[\*](#fn1){ref-type="fn"}**

Chair of Virology, University of Glasgow Centre for Virus Research (UK)

134 - Host Restriction of Schmallenberg Virus (20 min.)

**10:50--11:00 Break**

**C. David Pauza, PhD[\*](#fn1){ref-type="fn"}**

Institute of Human Virology, University of Maryland School of Medicine (US)

135 - HIV-associated immunodeficiency despite potent antiretroviral therapy with CD4 T cell reconstitution (20 min.)

**Michael Bukrinsky, MD, PhD**

Department of Microbiology, Immunology and Tropical Medicine at the George Washington University (US)

136 - HIV-1 Nef regulates activity of endoplasmic reticulum chaperone calnexin (20 min.)

**HONORARY LECTURE**

**V.I.Agol, MD, PhD, DSc**

M.P. Chumakov Institute of Poliomyelitis and Viral Encephalitis, Russian Academy of Medical Sciences (Russia)

137 - Interplay Between Host Defenses and Viral Anti-defenses: A Major Factor of Cytopathogenicity of Picornaviruses (35 min.)

**12:15--13:30 Lunch**

**13:30--17:00 Mechanisms for Virus Transmission**

Chairs: Salim Abdool Karim, M.D., Ph.D., President of South African Medical Research Council (South African Republic)[\*](#fn1){ref-type="fn"},

Saulius Chaplinskas, M.D., Ph.D., Director, Center for Communicable Diseases and AIDS, Vilnus, Lithuania

**PLENARY LECTURE:**

**Diane Griffin MD, PhD[\*](#fn1){ref-type="fn"}**

Alfred and Jill Sommer Professor, Chair of the Department of Molecular Microbiology and Immunology, the Johns Hopkins Bloomberg School of Public Health (US)

138 - Understanding protective immunity: Lessons from measles (30 min.)

**Barry J. Beaty, PhD[\*](#fn1){ref-type="fn"}**

University Distinguished Professor, Department of Microbiology, Immunology and Pathology, Colorado State University (US)

139 - Dengue Vector Control: Critical Needs and Opportunities for Helping to Control the Dengue Pandemic (20 min.)

**Myron Essex, DVM, PhD**

Mary Woodard Lasker Professor of Health Sciences Harvard School of Public Health, Harvard University (US)

140 - Reversing the Epidemic of HIV-1C in Southern Africa with Treatment as Prevention (20 min.)

**Steven O'Brien**

St. Petersburg State University (Russia)

141 - Gene Discovery and Data Sharing in Genome Wide Association Analyses: lessons from AIDS genetic restriction genes (20 min.)

**15:00--15:10 Break**

**E.A. Tkachenko, MD, PhD, DSc**

M.P. Chumakov Institute of Poliomyelitis and Viral Encephalitis, Russian Academy of Medical Sciences (Russia)

142 - Sochi Virus as a Highly Pathogenic and Life-threatening Agent (20 min.)

**Janusz T. Paweska, DVSc, dr hab, Prof Vet Sci[\*](#fn1){ref-type="fn"}**

Head, Centre for Emerging and Zoonotic Diseases, National Institute for Communicable Diseases National Health Laboratory Service (South African Republic)

143 - Rift Valley Fever Virus: a Virus with Potential for Global Emergence (20 min.)

**E.I.Korenberg**

Gamaleya Scientific Research Institute of Epidemiology and Microbiology of the Health Ministry of the Russian Federation

144 - Viral-Bacterial Mixed Infections Transmitted by Ticks: Diagnosis and Prevention in Russia (20 min.)

**Guodong Liang, MD[\*](#fn1){ref-type="fn"}**

National Institute for Viral disease Control and Prevention, China CDC (China)

145 - Arbovirus and Related Infectious Diseases in China (20 min.)

**Xiaoping Dong, PhD[\*](#fn1){ref-type="fn"}**

National Institute for Viral Disease Control and Prevention, China CDC (China)

146 - Understanding the Pathogenesis of Prion and Surveillance for Human Prion Diseases in China (20 min.)

**Saulius Chaplinskas, MD, PhD**

Director, Center for Communicable Diseases and AIDS (Lithuania)

147 - Globalization and New Challenges Caused of Communicable Diseases (20 min.)

Wednesday, September 11, 2013 {#s4}
=============================

Conference-Hall Sector B+C

**9:00--12:00 Viruses and Cancer**

Chairs: Volker Erfle, Helmholtz Centre (Germany)[\*](#fn1){ref-type="fn"},

A.D.Kaprin, M.D., Professor, Director of P.Herzen Moscow Research Oncology Institute of the Health Ministry of Russia

**OPENING COMMENT:**

**Robert C. Gallo, MD[\*](#fn1){ref-type="fn"}**

Institute of Human Virology, University of Maryland School of Medicine (US) (10 min.)

**Silvia Franceschi, MD**

Special Advisor, Head, Infections and Cancer Epidemiology Group, International Agency for Research on Cancer (IARC) (France)

148 - HPV, HIV, and Cancer: A Global Challenge (20 min.)

**Anna Linda Zignego, MD, PhD**

Director, Interdepartmental Center MaSVE, Department of Experimental and Clinical Medicine, University of Florence (Italy)

149 - HCV and Lymphoma (20 min.)

**Franco M. Buonaguro, MD[\*](#fn1){ref-type="fn"}**

Director, Molecular Biology and Viral Oncogenesis Unit, National Cancer Institute "Fondazione G. Pascale" (Italy)

150 - Carcinogenesis of HPV (20 min.)

**Patrick Moore, MD, MPH[\*](#fn1){ref-type="fn"}**

Professor, Department of Microbiology and Molecular Genetics, School of Medicine and Department of Infectious Diseases and Microbiology, University of Pittsburgh (US)

151 - Tumorigenic Polyoma Viruses (20 min.)

**10:20--10:40 Break**

**Luigi Chieco-Bianchi, MD[\*](#fn1){ref-type="fn"}**

Immunology and Molecular Oncology, Veneto Institute of Oncology, Dept of Surgery, Oncology & Gastroenterology, University of Padua (Italy)

152 - Insights into the pathogenesis of HHV8-driven body cavity lymphomas (20 min.)

**Masao Matsuoka, MD, PhD**

Institute for Virus Research, Kyoto University (Japan)

153 - Molecular Pathogenesis by HTLV-1 bZIP Factor (20 min.)

**William A. Blattner, MD**

Professor and Associate Director, Institute of Human Virology, University of Maryland School of Medicine (US)

154 - HIV and Cancer in Africa (20 min.)

**A.P. Kozlov**

Professor and Director, Biomedical Center (Russia)

155 - Evolution by Tumor Neofunctionalization and Phenomenon of Tumor Specifically Expressed, Evolutionarily Novel (TSEEN) Genes (20 min.)

**14:00--18:00 Clinical Management of Co-Morbidities in HIV/AIDS**

Chairs: John G. Bartlett, M.D., Director of the HIV Care Program, the Johns Hopkins Hospital (US), A.I.Mazus, M.D., Professor, Head of the Moscow City Centre for HIV/AIDS Prevention and Control (Russia)[\*](#fn1){ref-type="fn"}, Robert R. Redfield, M.D., Assistant Director of the Institute of Human Virology, University of Maryland School of Medicine (US)[\*](#fn1){ref-type="fn"}

**Barry Peters, MBBS, DFFP, MD, FRCP**

King's College London (UK)

156 - HIV and metabolic disease: Clues to control of HIV infection from the immune and virological response to high dose Vitamin D challenge (25 min.)

**Riccardo Dolcetti, MD**

Head, Cancer Bio-Immunotherapy Unit, IRCCS -- National Cancer Institute (Italy)

157 - Pathogenesis of Epstein-Barr Virus-driven Lymphomas of HIV+ Patients: new insights of potential clinical relevance (25 min.)

**Shyam Kottilil, MD, PhD**

National Institute of Allergy and Infectious Diseases (US)

158 - Hepatitis C Treatment Update: Current Status and Future Directions (25 min.)

**Rohit Talwani, MD[\*](#fn1){ref-type="fn"}**

Institute of Human Virology, University of Maryland School of Medicine (US)

159 - Hepatitis B Treatment Update: Current Status and Future Directions (25 min.)

**15:40--15:55 Break**

**Bruce Gilliam, MD[\*](#fn1){ref-type="fn"}**

Institute of Human Virology, University of Maryland School of Medicine (US)

160 - Treatment Strategies to Minimize the Impact of Antiretroviral Drug Toxicities (25 min.)

**E.M.Bogorodskaya, MD, PhD**

Moscow City Research and Practical Centre for Tuberculosis Control (Russia)

161 - Anti-tuberculosis Treatment for HIV-positive Patients in Moscow (20 min.)

**Abubakar Mussa Maghimbi, MD, MMed**

Institute of Human Virology (Tanzania)

162 - Confronting Tuberculosis in an African Population with HIV (20 min.)

**Patrick Mallon, MD, PhD**

Associate Dean for Research and Innovation, UCD School of Medicine and Medical Science (Ireland)

163 - HIV and kidney function with a focus on traditional risk factors and role of TDF, PI and other medication (25 min.)

**Closing remarks: A.I.Mazus[\*](#fn1){ref-type="fn"}, Robert R. Redfield[\*](#fn1){ref-type="fn"} (10 min.)**

Thursday, September 12, 2013 {#s5}
============================

GVN Meeting (closed) and Moscow International Virology Week Sessions

GVN Member
